Literature DB >> 17968951

Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

Ndate Fall1, Michael Barnes, Sherry Thornton, Lorie Luyrink, Judyann Olson, Norman T Ilowite, Beth S Gottlieb, Thomas Griffin, David D Sherry, Susan Thompson, David N Glass, Robert A Colbert, Alexei A Grom.   

Abstract

OBJECTIVE: Systemic juvenile idiopathic arthritis (JIA) is frequently associated with the development of macrophage activation syndrome. This study was undertaken to better understand the relationship between systemic JIA and macrophage activation syndrome.
METHODS: Gene expression profiles were examined in 17 patients with untreated new-onset systemic JIA, 5 of whom showed evidence of subclinical macrophage activation syndrome (of whom 2 eventually developed overt macrophage activation syndrome). Peripheral blood mononuclear cells (PBMCs) were separated on Ficoll gradients, and purified RNA was analyzed using Affymetrix GeneChip expression arrays. A fraction of the PBMCs were used for flow cytometry to define the cellular composition of the samples.
RESULTS: Two hundred twenty-five differentially expressed genes (P < 0.05) that distinguished patients with systemic JIA from healthy controls (n = 30) were identified. Clustering analysis indicated that expression patterns correlated with serum ferritin levels. Three main clusters distinguished systemic JIA patients with highly elevated ferritin levels (including those with subclinical macrophage activation syndrome) from those with normal or only moderately elevated ferritin levels. The first cluster comprised genes involved in the synthesis of hemoglobins and structural proteins of erythrocytes. This transcriptional profile was consistent with immature nucleated red blood cells, likely reflective of high red blood cell turnover. Also included were transcripts indicating immature granulocytes. The second cluster was enriched for genes involved in cell cycle regulation. The third cluster was enriched for genes involved in innate immune responses, including those involved in the negative regulation of Toll-like receptor/interleukin-1 receptor-triggered inflammatory cascades and markers of the alternative pathway of macrophage differentiation. Additional differentially expressed genes of interest were those involved in the cytolytic pathway, including SH2D1A and Rab27a.
CONCLUSION: These data indicate that gene expression profiling can be a useful tool for identifying early macrophage activation syndrome in patients with systemic JIA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968951     DOI: 10.1002/art.22981

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  106 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 2.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

3.  Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.

Authors:  Michael G Barnes; Alexei A Grom; Susan D Thompson; Thomas A Griffin; Paul Pavlidis; Lukasz Itert; Ndate Fall; Dawn Paxson Sowders; Claas H Hinze; Bruce J Aronow; Lorie K Luyrink; Shweta Srivastava; Norman T Ilowite; Beth S Gottlieb; Judyann C Olson; David D Sherry; David N Glass; Robert A Colbert
Journal:  Arthritis Rheum       Date:  2009-07

4.  Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.

Authors:  Thomas A Griffin; Michael G Barnes; Norman T Ilowite; Judyann C Olson; David D Sherry; Beth S Gottlieb; Bruce J Aronow; Paul Pavlidis; Claas H Hinze; Sherry Thornton; Susan D Thompson; Alexei A Grom; Robert A Colbert; David N Glass
Journal:  Arthritis Rheum       Date:  2009-07

5.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

6.  Juvenile idiopathic arthritis: management and therapeutic options.

Authors:  Natasha M Ruth; Murray H Passo
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

7.  Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome.

Authors:  Lehn K Weaver; Niansheng Chu; Edward M Behrens
Journal:  Arthritis Rheumatol       Date:  2018-11-24       Impact factor: 10.995

8.  Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.

Authors:  Patricia J Hunter; Kiran Nistala; Nipurna Jina; Ayad Eddaoudi; Wendy Thomson; Mike Hubank; Lucy R Wedderburn
Journal:  Arthritis Rheum       Date:  2010-03

9.  Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Authors:  Eli M Eisenstein; Dana G Wolf
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-20       Impact factor: 3.054

10.  Abatacept in difficult-to-treat juvenile idiopathic arthritis.

Authors:  Jasmin B Kuemmerle-Deschner; Sm Benseler
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.